Merck & Co., Inc. (MRK) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck & Company, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.073 Thank you for standing by. Welcome to Merck & Co., Inc., Broadway, New Jersey, USA, second 00:00:05.073 -- 00:00:07.655 quarter sales and earnings conference call. 00:00:07.655 -- 00:00:10.976 At this time, all participants are in a listen-only mode until the question and answer 00:00:10.976 -- 00:00:15.579 session of today's conference. At that time, to ask a question, please press star 1 on 00:00:15.579 -- 00:00:18.560 your phone and record your name at the prompt. 00:00:18.560 -- 00:00:22.302 This call is being recorded. If you have any objections, you may disconnect at this time. 00:00:22.302 -- 00:00:24.663 I would now like to turn the call over to Mr. 00:00:24.663 -- 00:00:27.765 Peter Dannenbaum, Senior Vice President, Investor Relations. 00:00:27.765 -- 00:00:30.245 Sir, you may begin. 00:00:31.047 -- 00:00:32.988 Thank you, Shirley, and good morning, everyone. 00:00:32.988 -- 00:00:37.772 Welcome to the second quarter 2026 conference call for Merck & Co., Inc., Raleigh, New 00:00:37.772 -- 00:00:42.675 Jersey, USA. Speaking on today's call will be Rob Davis, Chairman and Chief Executive 00:00:42.675 -- 00:00:46.298 Officer, Caroline Litchfield, Chief Financial Officer, and Dr. 00:00:46.298 -- 00:00:49.500 Dean Li, President of Research Labs. 00:00:49.500 -- 00:00:52.803 Before we get started, I'd like to point out that we have items in our GAAP results, 00:00:52.803 -- 00:00:56.746 such as acquisition-related charges, restructuring costs, and certain other items that 00:00:56.746 -- 00:00:59.130 we have excluded from our non-GAAP results. 00:00:59.130 -- 00:01:02.152 There is a reconciliation in our press release. 00:01:02.152 -- 00:01:05.274 I will also remind you that some of the statements that we make today may be cons...